ATAI
mental health disorders are one of the global health burdens in in every people or million people around the world were living with a mental disorder objective is to achieve clinically meaningful and sustained behavioral change in mental health patients by developing rapid acting and durable therapeutics eight clinical stage drug development programs and strategic investments each with a robust package of prior clinical evidence validated operating model and ability to capture value of compass pathways in and licensing deal between and subsidiary perception in cash marketable securities and committed term loan funding are expected to provide runway into life sciences healing so that everyone everywhere can live more life | ATAI
Company
Deck date
January 2024
Slide
3 of 34
Similar slides by ATAI
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Investor Presentation
March 2023
Related slides by other companies
Investor Presentation
February 2024
Investor Day
April 2022
Results
April 2023
Start Up
October 2014
Other recent decks by ATAI
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Investor Presentation
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io